[ALNY] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
07-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -49.96%
YoY- -99.52%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 44,714 33,294 21,033 2,069 29,907 21,899 37,924 11.63%
PBT -218,521 -181,220 -211,080 -244,837 -163,481 -141,276 -142,227 33.25%
Tax 960 695 361 445 79 -62 -7,949 -
NP -219,481 -181,915 -211,441 -245,282 -163,560 -141,214 -142,227 33.64%
Tax Rate - - - - - - - -
Total Cost 264,195 215,209 232,474 247,351 193,467 163,113 180,151 29.17%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin -490.86 -546.39 -1,005.28 -11,855.10 -546.90 -644.84 -375.03 19.71%
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -2.02 -1.73 -2.09 -2.43 -1.63 -1.41 -1.48 23.11%
EPS Diluted -2.02 -1.73 -2.09 -2.43 -1.63 -1.41 -1.48 23.11%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.